In summary, miRs that specifically target DNMT1 and modulate the methylation patterns of TSGs like BNIP3 and SPARC can potentially be utilised as a therapeutic approach for inducing apoptosis in pancreatic cancer cells and reducing their tumorigenic properties [76]. The gene discussed is SPARC; the disease is pancreatic neoplasm.